MIRA Pharmaceuticals (MIRA) Expected to Announce Quarterly Earnings on Monday

MIRA Pharmaceuticals (NASDAQ:MIRA) is projected to release its earnings data before the market opens on Monday, April 7th. Analysts expect MIRA Pharmaceuticals to post earnings of ($0.29) per share for the quarter.

MIRA Pharmaceuticals (NASDAQ:MIRA) last issued its quarterly earnings results on Friday, March 28th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.14. On average, analysts expect MIRA Pharmaceuticals to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

MIRA Pharmaceuticals Stock Performance

NASDAQ MIRA opened at $1.06 on Monday. The company has a market capitalization of $17.55 million, a PE ratio of -1.89 and a beta of 2.31. MIRA Pharmaceuticals has a 52-week low of $0.51 and a 52-week high of $5.01. The company has a 50-day simple moving average of $1.12 and a 200 day simple moving average of $1.22.

MIRA Pharmaceuticals Company Profile

MIRA Pharmaceuticals, Inc operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.